64
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Prognostic role of Toll-like receptors in cancer: a meta-analysis

, , , , &
Pages 1323-1330 | Published online: 30 Jul 2018

References

  • TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
  • AkiraSUematsuSTakeuchiOPathogen recognition and innate immunityCell2006124478380116497588
  • ShankaranVIkedaHBruceATIFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicityNature200141068321107111111323675
  • KawaiTAkiraSThe role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNat Immunol201011537338420404851
  • EySOuchiTThe application of Toll like receptors for cancer therapyJ Int J Biol Sci201067675681
  • KeoghBParkerAEToll-like receptors as targets for immune disordersTrends Pharmacol Sci201132743544221529972
  • LiewFYXuDBrintEKO’NeillLANegative regulation of toll-like receptor-mediated immune responsesNat Rev Immunol20055644645815928677
  • TaniguchiNKawaharaKYoneKHigh mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokineArthritis Rheum200348497198112687539
  • SoEYOuchiTThe application of Toll like receptors for cancer therapyInt J Biol Sci20106767568121060729
  • IwasakiAMedzhitovRToll-like receptor control of the adaptive immune responsesNat Immunol200451098799515454922
  • CammarotaRBertoliniVPennesiGThe tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic markerJ Transl Med2010811221059221
  • EiróNGonzálezLGonzálezLOToll-like receptor-4 expression by stromal fibroblasts is associated with poor prognosis in colorectal cancerJ Immunother201336634234923799413
  • EiróNOviesCFernandez-GarciaBExpression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosisArch Dermatol Res20133051596723179584
  • GrimmMKimMRosenwaldAToll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progressionEur J Cancer201046152849285720728343
  • StroupDFBerlinJAMortonSCMeta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) groupJAMA2000283152008201210789670
  • ParmarMKTorriVStewartLExtracting summary statistics to perform meta-analyses of the published literature for survival endpointsStat Med19981724281528349921604
  • EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
  • EiróNAltadillAJuárezLMToll-like receptors 3, 4 and 9 in hepatocellular carcinoma: relationship with clinicopathological characteristics and prognosisHepatol Res201444776977823742263
  • HuhtaHHelminenOLehenkariPPSaarnioJKarttunenTJKauppilaJHToll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett’s esophagus, dysplasia and adenocarcinomaOncotarget2016717236582366727008696
  • KimKHJoMSSuhDSExpression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancersWorld J Surg Oncol20121019322985132
  • LeppänenJHelminenOHuhtaHHigh toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patientsVirchows Archiv2017470440141028191612
  • MaFJLiuZBHuXPrognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patientsPLoS One2014910e11163925360699
  • PetricevicBVrbanecDJakic-RazumovicJExpression of Toll-like receptor 4 and beta 1 integrin in breast cancerMed Oncol201229248649421400218
  • WangELQianZRNakasonoMHigh expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancerBr J Cancer2010102590891520145615
  • ZhangJJWuHSWangLTianYZhangJHWuHLExpression and significance of TLR4 and HIF-1alpha in pancreatic ductal adeno-carcinomaWorld J Gastroenterol201016232881288820556833
  • ZheYLiYLiuDSuDMLiuJGLiHYExtracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathwayTumour Biol20163710139511395927492456
  • ChatterjeeSCrozetLDamotteDTLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancerCancer Res201474185008501825074614
  • HirvonenKBäckLHaglundCToll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glandsTumour Biol2016378109591096426888781
  • NiYHDingLZhangDYHouYYHuangXHuQDistinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinomaHistopathology201567573073925828894
  • Jukkola-VuorinenARahkoEVuopalaKSToll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancerJ Innate Immun200911596820375566
  • KauppilaJHKorvalaJSiiriläKToll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongueJ Oral Pathol Med201544857157725338738
  • KauppilaJHTakalaHSelanderKSLehenkariPPSaarnioJKarttunenTJIncreased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinomaHistopathology201159464364922014045
  • KorvalaJHarjulaTSiiriläKToll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosisJ Oral Pathol Med201443753053724484266
  • LeppänenJHelminenOHuhtaHHigh toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patientsVirchows Arch2017470440141028191612
  • RonkainenHHirvikoskiPKauppilaSAbsent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinomaJ Exp Clin Cancer Res2011308421929816
  • TuomelaJSandholmJKarihtalaPLow TLR9 expression defines an aggressive subtype of triple-negative breast cancerBreast Cancer Res Treat2012135248149322847512
  • VäisänenMRJukkola-VuorinenAVuopalaKSSelanderKSVaaralaMHExpression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancerOncol Lett2013551659166323761830
  • WłasiukPTomczakWZającMDmoszyńskaAGiannopoulosKTotal expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patientsHum Immunol201374121592159723994589
  • HayesDFIsaacsCStearnsVPrognostic factors in breast cancer: current and new predictors of metastasisJ Mammary Gland Biol Neoplasia20016437539212013528
  • MäkinenLKAtulaTHäyryVPredictive role of Toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinomaOral Oncol20155119610225264223
  • González-ReyesSMarínLGonzálezLStudy of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasisBMC Cancer20101066521129170
  • González-ReyesSFernándezJMGonzálezLOStudy of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrenceCancer Immunol Immunother201160221722620978888
  • BryantCESymmonsMGayNJToll-like receptor signalling through macromolecular protein complexesMol Immunol201563216216525081091
  • KoppEMedzhitovRRecognition of microbial infection by Toll-like receptorsCurr Opin Immunol200315439640112900270
  • DajonMIribarrenKCremerIToll-like receptor stimulation in cancer: a pro- and anti-tumor double-edged swordImmunobiology201722218910027349597
  • Moradi-MarjanehRHassanianSMFiujiHToll like receptor signaling pathway as a potential therapeutic target in colorectal cancerJ Cell Physiol201823385613562229150944